Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents. (Q45995397)

18 December 2017

title

Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents. (English)

1 reference

18 December 2017

0 references

7

Mulugeta Million

1 reference

18 December 2017

9

Yvette Taché

1 reference

18 December 2017

1

Guillaume Gourcerol

1 reference

18 December 2017

Tamer Coskun

2

1 reference

18 December 2017

Libbey S Craft

3

1 reference

18 December 2017

John P Mayer

4

1 reference

18 December 2017

Mark L Heiman

5

1 reference

18 December 2017

Lixin Wang

6

1 reference

18 December 2017

David H St-Pierre

8

1 reference

18 December 2017

publication date

1 November 2007

1 reference

18 December 2017

published in

Obesity

1 reference

18 December 2017

volume

15

1 reference

18 December 2017

issue

11

1 reference

18 December 2017

page(s)

2643-2652

1 reference

18 December 2017

Understanding and addressing the epidemic of obesity: an energy balance perspective

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Obestatin acts in brain to inhibit thirst

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Epidemiologic and economic consequences of the global epidemics of obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Regulation of food intake by gastrointestinal hormones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Ghrelin: structure and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Vaccination against weight gain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

GPR39 signaling is stimulated by zinc ions but not by obestatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Effects of obestatin on energy balance and growth hormone secretion in rodents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Obestatin--a ghrelin-associated peptide that does not hold its promise to suppress food intake and motility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Adrenergic, cholinergic and VIP-ergic influence on gastric phasic motility in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Ghrelin stimulates gastric acid secretion and motility in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Is somatostatin or a somatostatin-like peptide involved in central nervous system control of gastric secretion?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Bombesin acts in the brain to decrease gastric vagal efferent discharge in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Devazepide Attenuates dl-Fenfluramine-Induced Suppression of Gastric Emptying but Not Food Intake in the 17 h Food-Deprived Rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Coordinated gastric and sphincter motility evoked by intravenous CCK-8 as monitored by ultrasonomicrometry in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

CCK-resistance in Zucker obese versus lean rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Characterisation of proghrelin peptides in mammalian tissue and plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Obestatin improves memory performance and causes anxiolytic effects in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Obestatin alters sleep in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Role of brainstem TRH/TRH-R1 receptors in the vagal gastric cholinergic response to various stimuli including sham-feeding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Somatostatin: central nervous system (CNS) action on glucoregulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Corticotropin-releasing factor receptor 1-deficient mice do not develop postoperative gastric ileus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

Obestatin is not elevated or correlated with insulin in children with Prader-Willi syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.316

31 March 2020

Identifiers

DOI

10.1038/OBY.2007.316

1 reference

18 December 2017

PubMed ID

18070755

1 reference

18 December 2017